Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Who this might be right for
Atrial Fibrillation
Bayer 1,504